NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,046,431 | $19,861,000 | 4.55% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,702,002 | $8,847,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $38,000 | 0.03% |
| Hudock, Inc. | 27,500 | $36,000 | 0.02% |
| NOMURA HOLDINGS INC | 4,631,059 | $6,250,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 491,780 | $649,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 45,535 | $60,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $24,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 71,463 | $94,000 | 0.01% |
| SII INVESTMENTS INC/WI | 63,115 | $83,000 | 0.01% |